8-K

Company

ELITE PHARMACEUTICALS INC /NV/

Filed

June 11, 2014

Period of Report

May 23, 2014

Accession Number

0001144204-14-036879

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →